MedTrace Logo

Prospective Registration and Assessment of Serious Adverse Events Within the AFNET

NCT01678456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13000

Last updated 2020-09-22

No results posted yet for this study

Summary

Prospective registration and independent assessment of SAE associated with atrial fibrillation such as thromboembolic events, and other cardiac and noncardiac complications by a Critical Event Committee.

Conditions

  • Atrial Fibrillation
  • Assessment of Serious Advers Events
  • Thromboembolic and Bleeding Complications
  • Complications of Antiarrhythmic Drugs or Invasive Procedures
  • Assessment by a Critical Event Committee

Sponsors & Collaborators

  • Atrial Fibrillation Network

    lead OTHER

Principal Investigators

  • Michael Oeff, Professor · SAE-Zentrum Brandenburg/Havel Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2012-10-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01678456 on ClinicalTrials.gov